France will become the first country in the European Union to reimburse anti-obesity drugs through its public healthcare system, Health Minister Stéphanie Rist announced on Thursday (28 May).
From mid-June, severely obese patients in France will be able to receive partial or full reimbursement for weight-loss injections Wegovy and Mounjaro under the national social security system.
The move marks a major shift in access to obesity treatment in Europe, where the high cost of the drugs has remained a barrier for many patients.
“We are the first country in the European Union to provide reimbursement for patients who need it, under general law, on a permanent basis,” Rist said during an interview with TF1 television.
The treatment will be available to adults with severe obesity who meet strict medical criteria.
Patients with a body mass index (BMI) of at least 35 and at least one obesity-related illness will qualify. Those with a BMI of 40 or above will also be eligible, even without additional health conditions.
The drugs will officially be reimbursed at a rate of 65%. However, Rist said most eligible patients are likely to receive full coverage because many already qualify for 100% reimbursement due to related medical conditions.
“The target population is around one million people. However, this does not mean that everyone will receive the treatment, as it always depends on the individual case and the doctor’s prescription,” she said.
Wegovy, produced by Danish pharmaceutical company Novo Nordisk, and Eli Lilly’s Mounjaro have become some of the world’s most sought-after obesity treatments in recent years.
The drugs help patients lose weight by regulating appetite and blood sugar levels. Demand has surged globally as governments and healthcare systems seek ways to tackle rising obesity rates.
In France, the treatments have been available by prescription since 2024, but patients have until now had to cover the cost themselves. Monthly treatment costs average around €300.
Rist estimated the reimbursement programme would eventually cost the French state around €100 million per year as prescriptions increase.
Last year, France also widened access by allowing all doctors, not just specialists such as endocrinologists, to prescribe the treatments.
According to a French study published in 2024, around 18% of France’s population - roughly 10 million people - are obese.
As of January this year, more than 70,000 patients in France were already being treated with Mounjaro, according to estimates.
Health officials said the reimbursement programme is intended to help patients suffering from chronic obesity-related conditions rather than support cosmetic weight loss.
“It addresses a growing public health challenge and the urgency of appropriate therapeutic care,” said Étienne Tichit, General Manager of Novo Nordisk France.
Mike Doustdar, president and chief executive of Novo Nordisk, said the decision showed “the foresight and maturity of the French system.”
The decision comes as competition in the obesity drug market continues to intensify.
Novo Nordisk and Eli Lilly have both launched oral versions of their weight-loss treatments in the U.S. Last week, the European Medicines Agency recommended approval of Novo Nordisk’s Wegovy pill, which could become the first oral anti-obesity drug available in Europe.
In the UK, weight-loss drugs including Wegovy and Mounjaro are available on the NHS, but access remains limited under strict eligibility criteria. Patients typically need to meet BMI thresholds and have obesity-related health conditions.
The U.S. says it has launched strikes on Iran after alleged attacks on three commercial vessels in the Strait of Hormuz. Washington described the acti...
NATO leaders met Tuesday for the first day of a two-day summit in the Turkish capital Ankara, at which defence spending, Ukraine, and alliance unity t...
Pakistan's military on Monday linked cross-border militancy, hybrid threats and water security during the 276th Corps Commanders' Conference, reaffirm...
The U.S. says it has launched strikes on Iran after alleged attacks on three commercial vessels in the Strait of Hormuz. Washington described the action as a response to threats against civilian shipping and a breach of the ceasefire.
NATO leaders met Tuesday for the first day of a two-day summit in the Turkish capital Ankara, at which defence spending, Ukraine, and alliance unity topped the agenda.
Ramzan Kadyrov has been left off the ruling United Russia party's election list for Chechnya for the first time since 2007, fuelling fresh speculation about his political future and succession plans.
NATO leaders are unveiling multi-billion-dollar arms deals in Ankara as President Donald Trump joins the summit, highlighting Europe's increased defence spending amid tensions over Russia and Iran, and following years of U.S. criticism of the alliance.
The U.S. says it has launched strikes on Iran after alleged attacks on three commercial vessels in the Strait of Hormuz. Washington described the action as a response to threats against civilian shipping and a breach of the ceasefire.
The death toll from Venezuela's devastating twin earthquakes has risen to 3,342, according to the country's information ministry, as rescue teams continue searching affected areas and survivors face an uncertain recovery.
NATO leaders are unveiling multi-billion-dollar arms deals in Ankara as President Donald Trump joins the summit, highlighting Europe's increased defence spending amid tensions over Russia and Iran, and following years of U.S. criticism of the alliance.
Christian Dior has secured one of fashion's most coveted celebrity endorsements after both Taylor Swift and Travis Kelce wore custom haute couture designs by creative director Jonathan Anderson for their wedding in New York.
Massive crowds are gathering in the streets of Tehran on Monday for the funeral procession of Iran's slain former supreme leader, Ali Khamenei, as part of a week-long farewell. His son and designated successor, Mojtaba Khamenei, has yet to make a public appearance.
NATO leaders met Tuesday for the first day of a two-day summit in the Turkish capital Ankara, at which defence spending, Ukraine, and alliance unity topped the agenda.
Ramzan Kadyrov has been left off the ruling United Russia party's election list for Chechnya for the first time since 2007, fuelling fresh speculation about his political future and succession plans.
NATO leaders are unveiling multi-billion-dollar arms deals in Ankara as President Donald Trump joins the summit, highlighting Europe's increased defence spending amid tensions over Russia and Iran, and following years of U.S. criticism of the alliance.
Australia and the Solomon Islands have pledged to strengthen bilateral ties while condemning China's recent ballistic missile test in the Pacific, warning that the launch risks undermining regional stability.
French far-right leader Marine Le Pen has been sentenced on appeal to three years in prison, with two years suspended.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment